Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Robert W Baird Global Healthcare Conference (Virtual) Transcript

Sep 10, 2020 / 02:15PM GMT
Release Date Price: $214.96 (+2.42%)
Eric White Coldwell
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Okay. Jim, I think we are now live. Good morning, everyone. This is Eric Coldwell. I'm Baird's Healthcare Services and Supply Chain analyst. It's our pleasure today to have Charles River with us. Of course, Jim Foster, Chairman, President and CEO; also in the background, Todd Spencer, VP of IR.

Jim, we're going to jump straight in. I think you might have a few prepared comments, and then we'll go straight to fireside chat.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Sure. Nice to be here. Eric, nice to see you.

We talked about some favorable trends in August when we had our second quarter call. And so I'm pleased to say that -- sorry, favorable trends in July. So I'm pleased to say that those trends continued in August. And we're pleased with how the third quarter is shaping up. And we expect that all segments will report improved growth in the third quarter. So we feel really good about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot